Pioglitazole and metformin hydrochloride 15 mg/1

Pioglitazone and metformin hydrochloride 15 mg/1 tablets combine two antidiabetic agents for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Pioglitazone and metformin hydrochloride 15 mg/1 tablets are commonly used to manage type 2 diabetes. These tablets work by improving insulin sensitivity and reducing glucose production in the liver. They are often prescribed when diet and exercise alone are not sufficient to control blood sugar levels. This combination therapy is designed to help maintain stable glucose levels throughout the day.

Common effects of pioglitazone and metformin hydrochloride 15 mg/1 tablets may include mild gastrointestinal discomfort, such as nausea or diarrhea. Some users might experience weight gain or fluid retention. These effects are generally temporary and may subside as the body adjusts to the medication. If any effects persist or worsen, it is advisable to consult a healthcare provider.

Pioglitazone and metformin hydrochloride 15 mg/1 tablets should be handled with care. They are not suitable for everyone, particularly those with severe kidney or liver issues. It is important to follow the prescribed dosage and avoid alcohol while using this medication. Regular monitoring of blood sugar levels is recommended to ensure the medication's effectiveness and safety.

Pioglitazone and metformin hydrochloride 15 mg/1 tablets may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol can also interfere with the effectiveness of this medication. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.